Obesity and Cardiac Remodeling in Adults: Mechanisms and Clinical Implications

Progress in Cardiovascular Diseases

Volumn 61, Issue 2, 2018, Pages 114-123

  Alpert, Martin A ^a   Karthikeyan, Kamalesh ^a   Abdullah, Obai ^a   Ghadban, Rugheed ^a  

^a University of Missouri   (United States)

Author keywords

Cardiac output; Left ventricular diastolic dysfunction; Left ventricular hypertrophy; Metabolic abnormalities; Neurohormonal abnormalities; Obesity; Sleep disordered breathing

Indexed keywords

ADIPONECTIN; LEPTIN; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS;

ADAPTATION; ADRENERGIC SYSTEM; CARDIAC LIPOTOXICITY; CARDIAC MORPHOLOGY; DIABETIC CARDIOMYOPATHY; DISEASE ASSOCIATION; EXERCISE; GEOMETRY; HEART; HEART FUNCTION; HEART HEMODYNAMICS; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE DIASTOLIC FUNCTION; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE SYSTOLIC FUNCTION; HEART OUTPUT; HEART RIGHT VENTRICLE; HEART VENTRICLE REMODELING; HEMODYNAMICS; HUMAN; HYPERINSULINEMIA; HYPERTENSION; INSULIN RESISTANCE; LIPOTOXICITY; OBESITY; PATHOPHYSIOLOGY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SYSTEMIC VASCULAR RESISTANCE; ANIMAL; BODY WEIGHT LOSS; CARDIAC MUSCLE; CARDIOVASCULAR DISEASE; ENERGY METABOLISM; HEART LEFT VENTRICLE FUNCTION; HEART RIGHT VENTRICLE FUNCTION; METABOLISM; PROGNOSIS; RISK FACTOR;

ANIMALS; CARDIOVASCULAR DISEASES; ENERGY METABOLISM; HEART; HEMODYNAMICS; HUMANS; MYOCARDIUM; NEUROTRANSMITTER AGENTS; OBESITY; PROGNOSIS; RISK FACTORS; VENTRICULAR FUNCTION, LEFT; VENTRICULAR FUNCTION, RIGHT; VENTRICULAR REMODELING; WEIGHT LOSS;

EID: 85051374973     PISSN: 00330620     EISSN: 18731740     Source Type: Journal    
DOI: 10.1016/j.pcad.2018.07.012     Document Type: Review

References (144)

1. Alpert, M.A., Lavie, C.J., Aggarwal, K., Kumar, S.A., Obesity and heart failure: epidemiology, pathophysiology, clinical manifestations and management. Transl Res 164 (2014), 345–356.
2. Alpert, M.A., Agrawal, H., Aggarwal, K., Kumar, S.A., Kumar, A., Heart failure and obesity in adults: pathophysiology, clinical manifestations and management. Curr Heart Fail Rep 11 (2014), 156–165.
3. Lavie, C.J., Alpert, M.A., Arena, R., Mehra, M.R., Milani, R.V., Ventura, H.D., Impact of obesity and the obesity paradox on prevalence and prognosis in heart failure. J Am Coll Cardiol Heart Fail 1 (2013), 93–102.
4. Ebong, I.A., Goff, D.C. Jr., Rodriguez, C.J., Chen, H., Benton, A.G., Mechanisms of heart failure in obesity. Obes Res Clin Pract 8 (2014), e540–e548.
5. Poirier, P., Giles, T.D., Bray, G.A., et al. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity. Circulation 113 (2006), 898–918.
6. Harmancey, R., Wilson, C.R., Taegtmeyer, H., Adaptation and maladaptation of the heart in obesity. Hypertension 52 (2008), 181–187.
7. Alpert, M.A., Obesity cardiomyopathy. Pathophysiology and evolution of the clinical syndrome. Am J Med Sci 321 (2001), 225–236.
8. Lavie, C.J., Milani, R.V., Ventura, H.O., Obesity and cardiovascular disease: risk factors, paradox and impact of weight loss. J Am Coll Cardiol 53 (2009), 1925–1932.
9. Alpert, M.A., Omran, J., Mehra, A., Ardhanari, S., Impact of obesity and weight loss on cardiac performance and morphology in adults. Prog Cardiovasc Dis 56 (2014), 391–400.
10. Abel, E.D., Litwin, S.E., Sweeney, G., Cardiac remodeling in obesity. Physiol Rev 88 (2008), 389–419.
11. Wong, C., Marwick, T.H., Obesity cardiomyopathy: pathogenesis and pathophysiology. Nat Clin Pract Cardiovasc Med 4 (2007), 436–443.
12. Alexander, J.K., Alpert, M.A., Hemodynamic alterations with obesity. Alpert, M.A., Alexander, J.K., (eds.) The heart and lung in obesity, 1998, Futura Publishing Co., Armonk NY, 45–56.
13. Alexander, J.K., Obesity and cardiac performance. Am J Cardiol 14 (1964), 860–865.
14. Alexander, J.K., Dennis, E.W., Smith, W.G., et al. Blood volume, cardiac output and distribution of systemic blood flow in extreme obesity. Cardiovasc Res Cent Bull 1 (1962), 38–44.
15. DeDivtiis, O., Fazio, S., Petitto, M., et al. Obesity and cardiac function. Circulation 64 (1981), 447–482.
16. Alaud-din, A., Meteressian, S., Lisbona, R., et al. Assessment of cardiac function in patients who were morbidly obese. Surgery 92 (1982), 226–235.
17. Kasper, E.K., Hruban, R.H., Baughman, K.L., Cardiomyopathy of obesity: a clinical pathological evaluation of 43 obese patients with heart failure. Am J Cardiol 70 (1992), 921–924.
18. Neeland, I.J., Gupta, S., Ayers, C.R., et al. Relation of regional fat distribution to left ventricular structure and function. Circ Cardiovasc Imaging 6 (2013), 800–807.
19. Jern, S., Bergbrant, A., Bjontrop, P., Hansson, L., Relation of central hemodynamics to obesity and body fat distribution. Hypertension 19 (1992), 520–527.
20. Farag, N.H., Matthews, S.C., Brzezinski, E., Nelesen, R.A., Mills, P.J., Relationship between central obesity and cardiovascular hemodynamic indices in post-menopausal women. Fertil Steril 81 (2004), 465–467.
21. Koch, R., Sharma, A.M., Obesity and cardiovascular hemodynamic function. Curr Hypertens Rep 1 (1999), 127–130.
22. Fazio, S., Ferraro, S., De Simone, G., et al. Hemodynamic adaptation in severe obesity with or without arterial hypertension. Cardiologia 34 (1989), 967–972.
23. Good, D., Morse, S.A., Ventura, H.O., Reisin, E., Obesity, hypertension and the heart. J Cardiometab Syndr 3 (2009), 169–172.
24. Messerli, F.H., Christie, B., DeCavalio, J.G.B., Aristiamino, G.G., Obesity and essential hypertension. Hemodynamics, intravascular volume, sodium excretion and plasma renin activity. Arch Intern Med 141 (1981), 88–95.
25. Messerli, F.H., Sundgaard-Riise, K., Reisen, E.D., et al. Dimorphic cardiac adaptation to obesity and arterial hypertension. Ann Intern Med 99 (1983), 757–761.
26. Kaltman, A.J., Goldring, R.M., Role of circulatory congestion in the cardiorespiratory failure of obesity. Am J Med 60 (1976), 645–653.
27. Backman, C., Freyschuss, U., Hallberg, et al. Cardiovascular function in extreme obesity. Acta Med Scand 193 (1973), 437–446.
28. Alexander, J.K., Historical notes. Alpert, M.A., Alexander, J.K., (eds.) The heart and lung in obesity, 1998, Futura Publishing Co., Armonk NY, 1–10.
29. Bedford, E., The study of fatty heart. A disease of Victorian times. Br Heart J 34 (1972), 23–28.
30. Senac, J.B., Traite’ de la structure du coeur, de son action, et de ses maladies. 2nd Edition, Vol 2, 1783, Mequignon, Paris, 384.
31. Corvisart, J.N., Essai Sur Les Maladies et les Lesions Organiques du Coeur et des Gros Baisseaux. 1806, Migneret, Paris.
32. Laennec, R.T.H., De'l’Ausculation Mediate ou Traite’ du Diagnostic des Maladies des Poumons et du Coeur. Vol 2, 1819, Brosson and Chaude, Paris, 295.
33. Morgan, A.D., Some forms of undiagnosed coronary disease in nineteenth century England. Med Hist, 12, 1968, 344.
34. Quain, R., On fatty disease of the heart. Med Clin Trans 33 (1850), 121–194.
35. Harvey, W., Anatomical examination of the body of Thomas Parr. Harvey, W., (eds.) Works of William Harvey, translated from the Latin by Robert Willis, 1847, Sydenham Society, London, 589.
36. Smith, H.L., Willius, F.A., Adiposity of the heart. Arch Intern Med 52 (1933), 911–931.
37. Olsen, A.M., Willius, F.A., Clinic on cardiac failure resulting from pulmonary hypertension (Ayerza's disease) complicated by arterial hypertension and marked obesity. Proc Staff Meet Mayo Clin 14 (1939), 89–91.
38. Auchincloss, J.H. Jr., Cook, E., Renzetti, A., Polycythemia of unknown cause with alveolar hypoventilation. Clin Res Proc 3 (1955), 31–32.
39. Lillington, G.A., Anderson, M.A., Brandenberg, R.O., The cardiorespiratory syndrome of obesity. Dis Chest 32 (1957), 1–20.
40. Alpert, M.A., Alexander, J.K., Cardiac morphology and obesity in man. Alpert, M.A., Alexander, J.K., (eds.) The heart and lung in obesity, 1998, Futura Publishing Co., Armonk, NY, 25–49.
41. Amad, R.H., Brennan, J.C., Alexander, J.K., The cardiac pathology of obesity. Circulation 32 (1965), 740–745.
42. Alexander, J.K., Pettigrove, J.K., Obesity and congestive heart failure. Geriatrics 22 (1967), 101–108.
43. Warnes, C.A., Roberts, W.C., The heart in massive (more than 300 pounds or 136 kilograms) obesity. Analysis of 12 patient studies at necropsy. Am J Cardiol 54 (1989), 1087–1091.
44. Aurigemma, G.P., de Simone, G., Fitzgibbons, T.P., Cardiac remodeling in obesity. Circ Cardiovasc Imaging 6 (2013), 442–452.
45. Iacobellis, G., Ribaudo, M.C., Leto, G., et al. Influence of excess fat on cardiac morphology and function and function in uncomplicated obesity. Obes Res 10 (2002), 767–773.
46. Alpert, M.A., Terry, B.E., Kelly, D.L., Effect of weight loss on cardiac chamber size, wall thickness and left ventricular function in morbid obesity. Am J Cardiol 55 (1985), 783–786.
47. Alpert, M.A., Terry, B.E., Mulekar, M., et al. Cardiac morphology and left ventricular function in morbidly obese patients with and without congestive heart failure. Am J Cardiol 80 (1997), 736–740.
48. Alpert, M.A., Lambert, C.R., Terry, B.E., et al. Effect of weight loss on left ventricular mass in non-hypertensive morbidly obese patients. Am J Cardiol 73 (1994), 918–921.
49. Bella, J.N., Devereux, R.B., Roman, M.J., et al. Relations of left ventricular mass to fat-free and adipose body mass: the Strong Heart Study. Circulation 98 (1998), 2538–2544.
50. Alpert, M.A., Lambert, C.R., Panayiotou, H., et al. Relation of duration of morbid obesity to left ventricular mass, systolic function and diastolic filling, and effect of weight loss. Am J Cardiol 76 (1996), 1194–1197.
51. Nakajima, T., Fujioka, S., Tokunaga, K., et al. Non-invasive study of left ventricular performance in obese patients: influence of duration of obesity. Circulation 71 (1985), 481–485.
52. Danias, R.G., Tritos, N.A., Stuber, M., et al. Cardiac structure and function in the obese: a cardiac magnetic imaging study. J Cardiovasc Magn Reson 5 (2003), 431–438.
53. Antonini-Canterin, F., Mateescu, A.D., Vriz, O., et al. Cardiac structure and function and insulin resistance in morbidly obese patients: does superobesity play and additional role?. Cardiology 127 (2014), 114–151.
54. Woodwiss, A.J., Norton, G.R., Obesity and left ventricular hypertrophy: the hypertension connection. Curr Hypertens Rep, 17(4), 2015, 539, 10.1007/s 11906-015-0539-z.
55. Lauer, M.S., Anderson, K.M., Kannel, W.B., et al. The impact of obesity on left ventricular mass and geometry. JAMA 266 (1991), 231–236.
56. Woodwiss, A.J., Libhaber, C.D., Majane, O.H.I., et al. Obesity promotes left ventricular concentric rather than eccentric geometric remodeling and hypertrophy independent of blood pressure. Am J Hypertens 21 (2008), 1149–1153.
57. Peterson, L.R., Waggoner, A.D., Schectman, K.B., et al. Alterations in left ventricular structure and function in young healthy obese women. J Am Coll Cardiol 43 (2004), 1388–1404.
58. Lavie, C.J., Milani, R.V., Patel, D., et al. Disparate effects of hypertension and obesity on left ventricular geometry and mortality in 8088 elderly patients with preserved systolic function. Postgrad Med 121 (2009), 119–125.
59. Smalcelj, A., Pulievic, D., Bulijievic, B., et al. Left ventricular hypertrophy in obese hypertensive: is it really eccentric? (an echocardiographic study). Coll Antropol 24 (2000), 167–183.
60. Turkbey, E.B., McClelland, R.L., Kronmal, R.A., et al. The impact of obesity on the left ventricle; the multi-ethnic study of atherosclerosis (MESA). JACC Cardiovasc Imaging 3 (2010), 266–274.
61. Iacobellis, G., Ribaudo, M.C., Zappaterreno, A., et al. Adapted changes in left ventricular structure and function in severe uncomplicated obesity. Obes Res 12 (2004), 1616–1621.
62. Okpura, I.C., Adediran, O.S., Odia, O.J., et al. Left ventricular geometric patterns in obese Nigerian adults: an echocardiographic study. Internet J Intern Med 9 (2010), 1–7.
63. Tian, Z.Q., Zhong, J., Zhao, A.G., et al. Relationship between abdominal obesity and left ventricular weight/function. Zhounhua Xin Xue Bing Zen Zhi 35 (2007), 155–158.
64. Son, J.W., Fung, J.K., Lee, J.W., et al. Abdominal obesity and structure and function of the heart in healthy male Koreans. The ARIRANG study. Medicine, 95(39), 2016, e4930, 10.1097/MD.0000000000004930.
65. Wilner, B., Garg, S., Ayers, C.R., et al. Dynamic relation of changes in weight and indices of fat distribution with cardiac structure and function: the Dallas Heart Study. J Am Heart Assoc, 6, 2017, e005894, 10.1161/JAHA.117.005897.
66. Sasson, Z., Rasooly, Y., Gupta, R., et al. Left atrial enlargement, in healthy obese: prevalence and relation to ventricular mass and diastolic function. Am J Cardiol 12 (1996), 257–263.
67. Movahed, M.R., Saito, Y., Obesity is associated with left atrial enlargement, E/A reversal and left ventricular hypertrophy. Exp Clin Cardiol 13 (2008), 89–91.
68. Stritzke, J., Makus, M.R.P., Duderstadt, S., et al. The aging process of the heart: obesity is the main risk factor for left atrial enlargement during aging. J Am Coll Cardiol 54 (2009), 1982–1989.
69. Wong, C.Y., O'Moore-Sullivan, T., Leano, R., Ca, Hakins, Jenkins, C., Marwick, T.H., Association of subclinical right ventricular dysfunction with obesity. J Am Coll Cardiol 47 (2006), 611–616.
70. Chahal, H., McCleland, R.L., Tandai, H., et al. Obesity and right ventricular structure and function: the MESA-Right Ventricle Study. Chest 141 (2012), 388–395.
71. Chakko, S., Alpert, M.A., Alexander, J.K., Obesity and ventricular function in man: diastolic function. Alpert, M.A., Alexander, J.K., (eds.) The heart and lung in obesity, 1998, Futura Publishing Co., Armonk, NY, 57–76.
72. Chakko, S., Mayor, M., Allison, M.D., et al. Abnormal left ventricular diastolic filling in eccentric left ventricular hypertrophy of obesity. Am J Cardiol 68 (1991), 95–98.
73. Stoddard, M.F., Tseuda, K., Thomas, M., et al. The influence of obesity on left ventricular filling and systolic function. Am Heart J 124 (1992), 894–899.
74. Ku, C.S., Lin, S., Wang, D.J., et al. Left ventricular filling in young normotensive obese adults. Am J Cardiol 73 (1994), 613–615.
75. Goncalves, I.E., Rocha, M., Victor, E.G., et al. Echocardiography evaluation for asymptomatic patients with severe obesity. Arq Bras Cardiol 88 (2007), 48–53.
76. Pascual, M., Pascual, D.A., Soria, F., et al. Effects of isolated obesity in systolic and diastolic left ventricular function. Heart 89 (2003), 1152–1156.
77. Alpert, M.A., Lambert, C.R., Terry, B.E., et al. Effect of weight loss on left ventricular diastolic filling in morbid obesity. Am J Cardiol 80 (1997), 736–740.
78. Herszkowicz, H., Barbato, A., Salvi, W., et al. Contribution of Doppler echocardiography to the evaluation of systolic and diastolic function of obese women versus a control group. Arq Bras Cardiol 76 (2001), 189–196.
79. Scaglione, R., Dichiara, M.A., Indovina, A., et al. Left ventricular diastolic and systolic function in normotensive obese subjects: influence of degree and duration of obesity. Eur Heart J 13 (1992), 739–742.
80. Lee, S.L., Daimon, M., DiTullio, M.R., et al. Relationship of left ventricular diastolic function to obesity and overweight in a Japanese population with preserved left ventricular ejection fraction. Circ J 80 (2016), 1951–1956.
81. Ferraro, S., Perrone-Filardi, P., Desiderio, A., et al. Left ventricular systolic and diastolic function in severe obesity: a radionuclide study. Cardiology 87 (1996), 347–353.
82. Russo, C., Jin, Z., Hommu, S., et al. Effects of obesity and overweight on left ventricular diastolic function: a community-based study in an elderly cohort. J Am Coll Cardiol 57 (2011), 1368–1376.
83. Kossaify, A., Nicolais, N., Impact of overweight and obesity on left ventricular diastolic function and value of tissue Doppler echocardiography. Clin Med Insights Cardiol 7 (2013), 43–50.
84. Tanalp, A.C., Bitigen, A., Cevik, C., Demir, D., Ozveren, O., Tigen, K., The role of tissue Doppler study in the assessment of left ventricular dysfunction in obesity. Acta Cardiol 63 (2008), 541–546.
85. Otto, M.E., Belohlavek, M., Kandheria, B., Comparison of right and left ventricular function in obese and non-obese men. Am J Cardiol 93 (2004), 1569–1572.
86. Alpert, M.A., Alexander, J.K., Chakko, S., Obesity and ventricular function in man: systolic function. Alpert, M.A., Alexander, J.K., (eds.) The heart and lung in obesity, 1998, Futura Publishing Co., Armonk, NY, 77–94.
87. Alpert, M.A., Terry, B.E., Lambert, C.R., et al. Factors influencing left ventricular systolic function in non-hypertensive morbidly obese patients and effect of weight loss induced by gastroplasty. Am J Cardiol 75 (1993), 773–777.
88. Fung, J.K., Kim, J.Y., Obesity and preclinical changes of cardiac geometry and function. Korean Circ J 40 (2010), 55–56.
89. 2). Am J Cardiol 94 (2009), 1087–1090.
90. Tumuklu, M.M., Erika, I., Kumasi, B., et al. Effect of obesity on left ventricular structure and myocardial systolic function: assessment by tissue Doppler imaging and strain/strain rate imaging. Echocardiography 24 (2007), 802–809.
91. Ebaid, H., Ebaid, H.A., Mansour, H.A.E., Bastawisy, R.B., Elmeligy, N.A., Ibraheem, H.I., Role of tissue Doppler imaging and strain/strain rate imaging in the assessment of the effect of obesity on left ventricular structure and myocardial function. Int J Cardiovasc Res, 06(01), January 2014, 10.4172/2324-8602.10000300.
92. Abdul-Aziz, W.F., Yasmeen, R.I., Ahmed, A.M., Obada, M.A.H., Effects of isolated obesity on left ventricular function: a longitudinal strain imaging study. Menoufia Med J 27 (2014), 130–135.
93. Barbosa, M.M., Beleigoli, A.M., DE Fatima Diniz, M., et al. Strain imaging and morbid obesity: insight into subclinical ventricular dysfunction. Clin Cardiol 34 (2001), 288–293.
94. 2. Int J Cardiovasc Imaging 25 (2009), 272–277.
95. Myoshi, H., Yoshifumi, O., Mizaguchi, Y., et al. Contribution of obesity to left atrial and left ventricular dysfunction in asymptomatic patients with hypertension: a two-dimensional speckle-tracking echocardiographic study. J Am Soc Hypertens 8 (2014), 54–63.
96. Foppa, M., Arora, G., Gonap, et al. Right ventricular volumes and systolic function by cardiac magnetic resonance and impact of sex, age and obesity in longitudinally followed cohort free from pulmonary cardiac disease: the Framingham Heart Study. Circ Cardiovasc Imaging, 9(3), 2016 Mar, e003810, 10.1161/CIRCIMAGING.115.003810.
97. Orhan, A.L., Uslu, N., Davi, S.U., et al. Effects of isolated obesity on left and right ventricular function. A tissue Doppler and strain rate imaging study. Echocardiography 22 (2010), 236–243.
98. Sokmen, A., Sokmen, G., Gurlean, A., et al. The impact of isolated obesity on right ventricular function in young adults. Arq Bras Cardiol 101 (2013), 60–68.
99. Kalupahana, N.S., Moustaid-Moussa, W., The renin-angiotensin system: a link between obesity, inflammation and insulin resistance. Obes Rev 13 (2012), 136–149.
100. Underwood, P.C., Adler, G.K., The renin angiotensin aldosterone system and insulin resistance in humans. Curr Hypertens Rep 15 (2013), 59–70.
101. Frigolet, M.E., Torres, N., Tovar, A.R., The renin-angiotensin system in adipose tissue and its metabolic consequences during obesity. J Nutr Biochem 24 (2013), 2003–2015.
102. Lambert, G.W., Straznicky, N.E., Lambert, E.A., Dixon, J.B., Schlaich, M.P., Sympathetic nervous activation in obesity and the metabolic syndrome-causes, consequences and therapeutic implications. Pharmacol Therapeut 12 (2010), 157–172.
103. Amador, N., de Jesus Encarnacion, J., Rodriquez, L., et al. Relationship between left ventricular mass and heart sympathetic activity in male obese subjects. Arch Med Res 34 (2004), 411–415.
104. Snitker, S., McDonald, I., Ravussin, E., Astrup, A., The sympathetic nervous system and obesity: role in aetiology and treatment. Obes Rev 1 (2000), 5–15.
105. Tentolousis, N., Liatis, S., Katsilambros, N., Sympathetic system activity in obesity and metabolic syndrome. Ann N Y Acad Sci 108 (2006), 129–152.
106. Hall, M.E., Harmancey, R., Stec, D.E., Lean heart: role of leptin in cardiac hypertrophy and metabolism. World J Cardiol 7 (2015), 511–524.
107. Sweeney, G., Cardiovascular effects of leptin. Nat Rev Cardiol 7 (2010), 22–29.
108. Martinez-Martinez, E., Purado-Lopez, R., Cervantes Escalera, P., Cachofeiro, V., Miana, M., Leptin: a mediator of cardiac damage associated with obesity. Horm Mol Biol Clin Invest 18 (2014), 3–14.
109. Ghantous, C.M., Azrak, Z., Hanache, S., Abourkheir, W., Zeidan, A., Differential role of leptin and adiponectin in cardiovascular system. Int J Endocrinol, 2015, 2015, 534320, 10.1155/2005/534320.
110. Hopkins, T.A., Ouchi, N., Shibata, R., Walsh, K., Adiponectin actions in the cardiovascular system. Cardiovasc Res 74 (2007), 11–18.
111. McManus, D.D., Lyass, A., Ingelsson, E., et al. Relations of circulating resistin and adiponectin and cardiac structure and function: the Framingham Offspring Study. Obesity 20 (2012), 1882–1886.
112. Maia-Fernandes, T., Roncon-Albuquerque, R., Leite-Moreira, A.F., Cardiovascular actions of adiponectin: pathophysiologic implications. Rev Port Cardiol 27 (2008), 1431–1449.
113. Peterson, L.R., Obesity and insulin resistance: effects on cardiac structure, function, substrate metabolism. Curr Hypertens Rep 8 (2006), 451–456.
114. Iacobellis, G., Ribaudo, M.C., Zapaterrenno, A., et al. Relationship of insulin sensitivity and left ventricular mass in uncomplicated obesity. Obes Res 11 (2003), 518–524.
115. Kosmala, W., O'Moore-Sullivan, T., Plaksej, R., Przewlocka-Kosmala, M., Marwick, T.H., Improvement of left ventricular function by lifestyle intervention in obesity: contributions of weight loss and reduced insulin resistance. Diabetologia 52 (2009), 2306–2316.
116. McGavock, J.M., Victor, R., Unger, R.H., Szcezpaniak, L.S., Adiposity of the heart revisited. Ann Intern Med 144 (2006), 515–524.
117. Wende, A.R., Symons, J.D., Abel, D.E., Mechanisms of lipotoxicity in the cardiovascular system. Curr Hypertens Rep 14 (2012), 517–531.
118. Drosatos, K., Schulze, P.C., Cardiac lipotoxicity: molecular pathways and therapeutic implications. Curr Heart Fail Rep 10 (2013), 109–121.
119. Wende, A.R., Abel, E.D., Lipotoxicity in the heart. Biochim Biophys Acta 2010 (1801), 311–319.
120. Rijzewijk, L.J., van der Meen, R.W., Smit, J.W., et al. Myocardial steatosis is an independent predictor of diastolic dysfunction in type 2 diabetes mellitus. J Am Coll Cardiol 52 (2008), 1793–1799.
121. Korosoglou, G., Humpert, P.M., Ahrens, J., et al. Left ventricular diastolic function in type 2 diabetes mellitus is associated with myocardial triglyceride content but not with impaired myocardial perfusion reserve. J Magn Reson Imaging 35 (2012), 804–811.
122. Alexander, J.K., Petersen, K.L., Cardiovascular effects of weight reduction. Circulation 45 (1972), 310–318.
123. Backman, L., Freyschuss, U., Hallbert, D., et al. Reversibility of cardiovascular charges in extreme obesity. Effects of weight reduction through jejunoileostomy. Acta Med Scand 193 (1979), 367–373.
124. Ashrafian, H., le Roux, C.W., Darzi, A., et al. Effects of bariatric surgery on cardiovascular function. Circulation 118 (2008), 2091–2102.
125. Reisin, E., Frohlich, E.D., Messerli, F.H., et al. Cardiovascular changes after weight loss in obesity hypertension. Ann Intern Med 98 (1983), 315–319.
126. Rider, O.J., Franco, J.M., Ali, M.K., et al. Beneficial cardiovascular effects on bariatric surgical and dietary weight loss in obesity. J Am Coll Cardiol 54 (2009), 718–726.
127. Jhaveri, R.R., Pond, K.K., Hauser, T.H., et al. Cardiac remodeling after substantial weight loss: a prospective cardiac magnetic resonance study after bariatric surgery. Surg Obes Relat Dis 5 (2009), 648–652.
128. De las Fuentes, L., Waggoner, A.D., Mohammed, B.S., et al. Effect of moderate diet-induced weight loss and weight regain on cardiovascular structure and function. J Am Coll Cardiol 54 (2009), 2376–2381.
129. Cuspidi, C., Rescaldani, M., Taldic, M., Sala, C., Grassi, G., Effects of bariatric surgery on cardiac structure and function: a systematic review and meta-analysis. Am J Hypertens 27 (2014), 146–156.
130. Aggarwal, R., Harling, L., Efthimiou, E., Darzi, A., Athanasiou, T., Ashrafian, H., The effects of bariatric surgery on cardiac structure and function: a systematic review of cardiac imaging outcome. Obes Surg 26 (2015), 1030–1040.
131. Shin, S.H., Lee, Y.J., Heo, Y.S., et al. Beneficial effects of bariatric surgery on cardiac structure and function in obesity. Obes Surg 27 (2017), 620–625.
132. Grapsa, J., Tan, T.L., Paschou, S.A., et al. The effect of bariatric surgery on echocardiographic indices: a review of the literature. Eur J Clin Invest 43 (2013), 1224–1230.
133. Haufe, S., Utz, W., Engeli, S., et al. Left ventricular mass and function with reduced-fat or reduced-carbohydrate hypocaloric diets in overweight and obese subjects. Hypertension 59 (2012), 70–75.
134. Damiamo, S., De Marco, Del Genio F., et al. Effect of bariatric surgery on left ventricular geometry and function in severe obesity. Obes Res Clin Pract 6 (2017), e189–e196.
135. Owan, T., Avelar, E., Marely, K., et al. Favorable changes in cardiac geometry and function following gastric bypass surgery: 2-year follow-up in the Utah obesity study. J Am Coll Cardiol 57 (2011), 732–739.
136. Luaces, M., Cachofeiro, V., Garcia-Munoz-Najar, A., et al. Anatomical and functional alterations of the heart in morbid obesity. Changes after bariatric surgery. Rev Esp Cardiol 65 (2012), 14–21.
137. McCloskey, C.D., Ramani, G.V., Mathier, M.A., et al. Bariatric surgery improves cardiac function in morbidly obese patients with severe cardiomyopathy. Surg Obes Relat Dis 3 (2007), 503–507.
138. Vest, A.R., Patel, P., Schauer, P.R., et al. Clinical and echocardiographic outcomes after bariatric surgery in obese patients with left ventricular systolic dysfunction. Circ Heart Fail, 9(3), 2016 Mar, c002260, 10.1161/CIRCHEARTFAILURE.115.002260.
139. Alpert, M.A., Pitchett, A.M., Bariatric surgery in patients with left ventricular systolic dysfunction: effective, but is it safe?. Circ Heart Fail, 9, 2016, e002960, 10.1161/CIRCHEARTFAILURE.116.002960.
140. Kindel, T.L., Strande, R., Bariatric surgery as a treatment for heart failure: review of the literature and potential mechanisms. Surg Obes Relat Dis 14 (2018), 117–122.
141. Karimian, S., Stein, J., Bauer, B., Teupe, C., Impact of severe obesity on systolic left ventricular function and morphology: assessment by 2-dimensional speckle-tracking echocardiography. J Obes, 2016, 10.1153/2016/2732613.
142. Alexander, J.K., Alpert, M.A., Pathogenesis and clinical manifestations of obesity cardiomyopathy. Alpert, M.A., Alexander, J.K., (eds.) The heart and lung in obesity, 1998, Futura Publishing Co., Armonk NY, 133–146.
143. Estes, E.H., Sieker, H.O., McIntosh, H.D., et al. Reversible cardiopulmonary syndrome with extreme obesity. Circulation 16 (1957), 179–187.
144. Miranda, W.R., Batsis, J.A., Sarr, M.G., et al. Impact of bariatric surgery on quality of life functional capacity and symptoms in patients with heart failure. Obes Surg 23 (2013), 1101–1105.